ArticleBioinformatics (Oxford, England)2026
CycleVI: isolating cell cycle variation with an interpretable deep generative model.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
motivationCell cycle progression is a dominant source of variation in single-cell RNA sequencing (scRNA-seq) data, often obscuring other transcriptional signals of interest. Several methods have been developed to infer continuous cell cycle phase from transcriptomic data, but their estimates tend to be unstable when proliferation is intertwined with other biological processes or technical sources of heterogeneity.
resultsWe present CycleVI, a deep generative model that disentangles cell cycle-driven variation from other signals in scRNA-seq data using a partitioned latent representation with a dedicated circular subspace. CycleVI accurately infers a continuous cell cycle phase, validated against orthogonal protein-level measurements, and yields a residual latent space free of cell cycle artefacts. This disentangled representation helps resolve biological processes intertwined with the cell cycle, clarifying hematopoietic differentiation and preserving drug-response signals better than standard cell cycle regression. By isolating cell cycle-related variation rather than removing it, CycleVI provides a principled framework for analysing cellular heterogeneity in proliferating systems. AVAILABILITY: CycleVI is available at www.github.com/jeuken/CycleVI, or through the ' cyclevi' Python package.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.